Spinal Cord Area Loss Predicts Myelopathy in Severe Cervical Ossification
Percentage reduction in cord cross-sectional area shows higher diagnostic accuracy than traditional bony canal measurements.
Beta-1 Blockers May Reduce Vascular Dementia Risk in Genetic Analysis
A Mendelian randomization study suggests beta-1 adrenergic antagonism protects white matter, while ACE inhibition may increase risk.
Preconception Care Reduces Maternal and Neonatal Morbidity
A review highlights evidence-based interventions, from folic acid to chronic disease management, that optimize health before conception.
Rapid Susceptibility Testing Speeds Antibiotic Adjustments but Not Outcomes
While rapid testing accelerated antibiotic adjustments by 14 hours, it did not improve 30-day survival or reduce deleterious events.
Low-Calorie Feeding Does Not Worsen Kidney Function in Shock
A post hoc analysis of 3,036 patients shows early restrictive diets are safe for the kidneys, even with preexisting dysfunction.
Planetary Health Diet Linked to Lower Risk of Stroke and Depression
A UK Biobank study of 69,370 adults finds high adherence to sustainable eating reduces brain disorder risk via slower biological aging.
Resilience Alters Symptom Networks Linking Bullying to Depression in Adolescents
Network analysis reveals that low resilience strengthens the ties between social exclusion and depressive symptoms like anhedonia.
Rising Depressive Symptoms Precede Cardiovascular Disease by Over a Decade
A longitudinal analysis of nearly 50,000 adults identifies a sustained increase in depressive symptoms as a long-term prodromal phase of CVD.
Early DHEA Levels Predict Depression in Adolescent Males but Not Females
A longitudinal study finds that while DHEA at age nine increases risk for males, adrenal hormones do not explain higher female prevalence.
Home-Based Prefrontal Cortex Stimulation Reduces Subjective Stress Appraisal
A feasibility study of self-administered tDCS shows high adherence and safety, though physiological stress markers remained unchanged.
Four Months of Fingolimod Does Not Improve Anxiety or Depression in MS
A prospective study of 61 patients with relapsing-remitting MS found no significant changes in mood scores after initiating fingolimod.
Students With Moderate Distress Show High Rate of Worsening
A 10-month analysis finds this group is a key target for intervention, with problematic internet use predicting negative outcomes.